-
Mashup Score: 8Characterization of Sarcomatoid Urothelial Bladder Cancer Features and Treatment Options Using Patient-Derived Organoids - Expert Commentary - 10 hour(s) ago
Sarcomatoid urothelial bladder cancer (SARC), urothelial carcinoma (UC), glucocorticoid receptor (GR) agonists, bladder cancer, patient-derived organoids (PDOs) of SARC.
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 3Novel Use of Circulating Tumor DNA to Identify Muscle-Invasive and Non-organ-confined Upper Tract Urothelial Carcinoma - Beyond the Abstract - 16 hour(s) ago
upper tract urothelial carcinoma (UTUC), circulating tumor DNA (ctDNA), circulating tumor DNA in upper tract urothelial carcinoma, Non-organ-confined Upper Tract Urothelial Carcinoma, Muscle-invasive Upper Tract Urothelial Carcinoma.
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet-
Novel research on #UTUC: Can plasma ctDNA predict muscle-invasive and non-organ-confined staging? Exciting findings suggest ctDNA detection pre-nephroureterectomy could be a strong prognostic indicator in UTUC management. #BeyondTheAbstract @HHuelsterMD > https://t.co/BXLtI0oiT2 https://t.co/2uWE28SzuG
-
-
Mashup Score: 11
At the 2024 UCSF-UCLA PSMA Conference, Amar Kishan presents on metastasis-directed therapy (MDT) for oligometastatic prostate cancer, highlighting its potential to delay systemic therapy and improve progression-free survival (PFS) as evidenced by trials like STOMP, ORIOLE, EXTEND, and ARTO. Dr. Kishan emphasizes the role of PSMA PET imaging in identifying MDT candidates and calls for further…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 3Abortion rights amendment qualifies for the South Dakota ballot - 17 hour(s) ago
While opponents can still file legal challenges for another month, South Dakota is now the fourth state to put the abortion issue directly before voters this year.
Source: www.nbcnews.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 22Paul Parkman, an inventor of the rubella vaccine, dies at 91 - 17 hour(s) ago
His work helped identify — and eliminate from much of the world — a disease that can cause catastrophic birth defects and fetal death.
Source: www.washingtonpost.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 4More than 100 GPs protest in Birmingham in pay row - 18 hour(s) ago
Doctors said that a 1.9% increase for each patient brought in last month was not enough.
Source: www.bbc.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 0
Localities seeking to rethink the way they handle behavioral health crises also face a variety of barriers, from developing and financing these enhanced approaches to tracking outcomes.
Source: www.pewtrusts.orgCategories: General Medicine News, General NewsTweet
-
Mashup Score: 7
At the 2024 UCSF-UCLA PSMA Conference, Louise Emmett explores the interaction between PSMA and androgen receptors in prostate cancer, focusing on their role across different disease states and the impact on treatment and imaging. Dr. Emmett highlights the ENZA-P trial, a study investigating the combination of Enzalutamide with Lutetium PSMA in metastatic castrate-resistant prostate cancer,…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 1Route of Administration for UGN-101 and the Impact on Oncological & Safety Outcomes - Jennifer Linehan - 19 hour(s) ago
Sam Chang engages with Jennifer Linehan to discuss topical chemotherapy for upper tract urothelial carcinoma, particularly utilizing UGN-101 (Jelmyto). Dr. Linehan shares her invaluable insights and experiences, primarily from the OLYMPUS trial, highlighting the evolution in administration methods for UGN-101, transitioning from retrograde to the more convenient antegrade approach via a…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet-
Route of administration for #UGN-101 and the impact on oncological & safety outcomes. @Dr_Jen_Linehan @providencesocal and @UroCancerMD @VUMCurology discuss topical chemotherapy for #UTUC particularly utilizing @jelmyto in this discussion on UroToday > https://t.co/9ElulVWo7f https://t.co/744mj3r3kE
-
-
Mashup Score: 12EV-302: Enfortumab Vedotin + Pembrolizumab Outperforms Chemo in Untreated Advanced Urothelial Cancer - Michiel Simon Van der Heijden - 21 hour(s) ago
Sam Chang interviews Michiel Van der Heijden about the results of the EV-302 trial, comparing enfortumab vedotin plus pembrolizumab (EVP) against chemotherapy in previously untreated advanced urothelial cancer patients. Dr. Van der Heijden outlines the trial’s structure and its remarkable findings, noting the hazard ratios for progression-free and overall survival rates that favor EVP. He delves…
Source: www.urotoday.comCategories: General Medicine News, General NewsTweet
Characterization of sarcomatoid urothelial #BladderCancer features and treatment options using patient-derived organoids. #ExpertCommentary @FaltasLab discusses work by @Michele_Garioni et al. to study this rare but aggressive form of bladder cancer > https://t.co/dVOJDmMTyt https://t.co/WHpbuqsJDr